Orsini Specialty Pharmacy, a US-based company involved in rare diseases and gene therapies, announced on Thursday that it has named Victor Haddock as its new chief financial officer and Lynda Parker as executive vice president of Trade Relations and Account Management.

Haddock has more than 25 years of financial leadership experience in the healthcare sector. Most recently, he has served as CFO of Triple-S Management in Puerto Rico, and in leadership positions at MagellanRx and Express Scripts.

Parker has over 25 years of experience working in the pharmaceutical and biotech industry. She has served in leadership roles at companies such as Eisai, Ipsen, Syneos, Eversana and IQVIA and has experience in building patient support solutions, hub services and commercial support.